Skip navigation

Next-Generation Drug Conjugates: The Holistic View of Developing Superior Drug Conjugates

09:00 - 15:00

Location:
The Nucleus, Chesterford Research Park, Little Chesterford, Cambridge CB10 1XL
Date:
24 February 2016
 
Supported by:




By attending the One Nucleus Innovation Day on Next-Generation Drug Conjugates - The Holistic View of Developing Superior Drug Conjugates sponsored by Albumedix, you not only get the possibility to network with likeminded peers but also the latest update from industry professionals active in the vastly evolving field of drug conjugates. We will be joined not only by Albumedix' scientists, but leading companies in the development and manufacturing of conjugation chemistries as well as leading scientists from Pharma and academia.

Unlike other events focusing exclusively on antibody based drug conjugates, Innovation Day takes a look at some of the recent developments in non-antibody based next-generation drug conjugates. In connection, you will get a possibility to interact with thought leaders from innovative biotech companies actively exploring optimized routes for stable drug conjugation. 

Participating at the Innovation Day will spark a lot of interesting discussions and potentially new collaborations in one of the industry’s hottest field.

Programme:

09.00 -Registration and networking

09.30 - Welcome and Introduction
David Mead, Albumedix

To view the presentation, click here.


09.40 - Differentiated polypeptide dosing for patient adherence
Darrell Sleep, Albumedix
To view the presentation, click here.

10.05 - Chemistry on Proteins for Basic Biology and Therapeutics
Gonçalo Bernardes, University of Cambridge

10.35 - Coffee and tea

11.00 - Site-selective bioconjugates using Next Generation Maleimides
Jamie Baker,
ThioLogics

To view the presentationclick here.

11.25 - Drug conjugation to carriers
George Badescu, PolyTherics 
To view the presentation, click here.

11.50 - Superior stability and enhanced tumour response with PermaLink™ based protein conjugates
Justyna Mysliwy, Glythera
To view the presentation, click here.

12.15 - Chemistry of Conjugation
Alastair Hay, Almac
To view the presentation, click here.

12.40 - Half-life extension of coagulation factors using albumin fusion technology
Thomas Weimer, CSL
To view the presentation, click here.

13.05 - Lunch and networking

14.30 - Close 
Title: Next-Generation Drug Conjugates: The Holistic View of Developing Superior Drug Conjugates
Start: 2016-02-24 09:00:00Z
End: 2016-02-24 15:00:00Z